市場調査レポート

商品コード

体外診断薬市場規模・予測、世界・地域シェア、動向、成長機会分析レポート対象範囲：製品・サービス別、技術別、用途別、エンドユーザー別、地域別

In-Vitro Diagnostic Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product & Service, Technology, Application, End User, and Geography

出版日: 2023年09月18日
発行: The Insight Partners
ページ情報: 英文 210 Pages
納期: 即納可能

価格

PDF (Single User License)

USD 4,450 653,349円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,450 946,989円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,450 1,240,629円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

体外診断薬市場は、2022年の723億9,380万米ドルから2030年には1,121億351万米ドルに成長すると予測されており、2022年から2030年までのCAGRは5.6%と予想されています。慢性疾患の増加、技術の進歩、老年人口の増加が、体外診断薬市場の成長を促進する注目すべき要因です。

体外診断（IVD）とは、人体から採取した血液や組織などのサンプルを用いて行う検査のことです。体外診断薬は病気やその他の状態を検出することに特化しており、病気の治療、処置、予防に役立てるため、人の全体的な健康状態をモニターするために使用されます。さらに、体外診断薬は、特定の治療や療法の恩恵を受けそうな患者を特定する精密医療にも利用されることがあります。そのため、これらの体外診断には、ゲノム変異を検出するために人のDNAをスキャンする次世代シークエンシング検査が含まれます。

慢性疾患と感染症の有病率の増加

世界では感染症の流行が急激に増加しています。これらの病気は、ウイルス、細菌、寄生虫などの病原性微生物が主な原因です。劣悪な衛生環境、公衆衛生の欠如、大気汚染レベルの上昇、安全な飲料水の不足といった要因が、感染症の蔓延に大きな役割を果たしています。カナダ公衆衛生局によると、カナダでは2020年に合計6,736人のC型肝炎患者（急性、慢性、特定不能の合計）が報告されました。

慢性疾患には、がん、慢性呼吸器疾患、糖尿病、心臓病が多く含まれます。アルコールやタバコの消費量の増加、不健康な食生活の採用、運動不足、肥満の蔓延といった生物学的危険因子のために、これらの疾患の罹患率は世界的に急増しています。慢性疾患は世界の死亡原因の第1位です。米国疾病予防管理センター（CDC）によると、アメリカ人の10人に6人は、脳卒中、がん、心臓病、糖尿病など、少なくとも1つの慢性疾患を抱えて生活しています。これらの慢性疾患は、米国における死亡や身体障害の主な原因であり、急増するヘルスケアコストです。また、CDCのデータによると、心臓病は男性、女性、ほとんどの人種・民族の死亡原因のトップです。

CDCのデータによると、冠動脈疾患（CAD）は成人の死亡原因として最も一般的です。2021年には約375,476人がCADが原因で死亡しました。世界保健機関（WHO）の2022年全国糖尿病統計報告書に発表された推計によると、世界で4億2200万人が糖尿病を患っており、その大多数が低・中所得国に住んでいます。さらに、毎年150万人が糖尿病に直接関連して死亡しています。過体重、遺伝的条件、加齢、座りっぱなしのライフスタイルなどが糖尿病の有病率を押し上げています。Cancer Research UKの報告書に掲載された推計によると、2020年には世界で1,810万人の新規がん患者が報告され、その数は2040年までに2,800万人に増加すると予想されています。したがって、心血管疾患、がん、糖尿病、呼吸器疾患などの感染症や慢性疾患の有病率の上昇が、体外診断薬市場の成長を牽引しています。

市場動向

個別化医療とゲノミクスへの需要の高まり

北米は個別化医療とゲノミクス研究の最前線にあります。ゲノミクスと分子診断学の日常的な患者ケアへの統合が進んでいます。先進的な遺伝学の開発に携わる企業は、体外診断薬市場に大きなビジネスチャンスをもたらしています。北米、特に米国とカナダは、疾患の遺伝的基盤に関する理解と知識、バイオマーカーの同定、標的療法の開発に顕著に貢献するゲノム研究センターの拠点となっています。これら両国は、ゲノミクスを臨床診療に統合する精密医療イニシアチブを立ち上げています。北米はがんゲノミクスのリーダーであり、さまざまな種類のがんに関連する遺伝的要因の解明に焦点を当てた広範な研究や臨床試験が行われています。これらの臨床試験は、患者の腫瘍の遺伝的特徴に基づいて、標的療法、免疫療法、その他の革新的な治療法の有効性を評価することを目的としています。米国がん協会は、2023年には米国で190万人の新規がん患者（1日あたり5,370人）と609,820人のがんによる死亡が記録されると推定しています。このような高い罹患率に伴い、これらの患者の生活の質を改善するための効果的な治療が急務となっています。

個別化医療では、体外診断検査を患者に実施し、患者固有の特徴に基づいてサブグループに層別化します。個別化医療の分野は、ゲノム配列決定、分子プロファイリング、その他の診断技術の進歩とともに、標的を絞った精密で個別化された治療アプローチを提供することにより、ヘルスケアに革命をもたらす可能性を秘めています。遺伝学は世界的にますます身近なものとなっています。2022年11月、ロシュ、Cancer Research UK、マンチェスター大学は、多剤併用精密医療DETERMINE試験の開始を発表しました。この試験は、より一般的ながん種に対して認可されている薬剤を含め、利用可能な薬剤が希少がん種の患者に有益かどうかを評価することを目的としています。この試験では、希少がん種の成人および小児患者を募集しました。23andMe社やAncestryDNA社などの企業は、直接消費者に遺伝子検査キットを提供し、個人が自分の先祖や遺伝的特徴、潜在的な健康リスクについて洞察を得ることを可能にしています。ヘルスケアプロバイダーもまた、治療方針を決定するための遺伝子検査を提供しています。このように、個別化医療とゲノミクスの需要は、予測期間中の体外診断薬市場の成長を促進すると思われます。

体外診断の世界市場」は、製品・サービス、用途、技術、エンドユーザー、地域によって区分されます。製品・サービスに基づき、市場は試薬・キット、機器、ソフトウェア・サービスに区分されます。2022年には、試薬とキットのセグメントが市場で最大のシェアを占めています。試薬・キット市場の成長が予測される背景には、自己検査キットやPOCデバイスの絶大な人気、作業を簡素化し正確な結果を提供する自動化機器の入手可能性と導入の増加があります。また、ウイルスや真菌による感染症が増加し、衛生状態が十分でないことが試薬の使用を促進しています。したがって、体外診断薬市場のプレーヤーは、より良い患者管理とケアのために、優れた品質の分子試薬とキットを提供しています。

欧州医薬品庁、緊急使用認可、疾病管理予防センター、国際糖尿病連合、体外診断研究は、体外診断市場調査報告書作成時に参照した関連情報源の一部です。

市場促進要因
- 慢性疾患と感染症の有病率の増加
- COVID-19パンデミック時の体外診断薬需要の急増
市場抑制要因
- 規制枠組みおよび償還政策の不十分さ
市場機会
- IVDとデジタルヘルス技術の統合
今後の動向
- 個別化医療とゲノミクスへの需要の高まり

第6章体外診断薬市場-世界市場分析

体外診断薬市場の収益、2022年～2030年

第7章体外診断薬の世界市場-2030年までの収益と予測-製品・サービス別

2022年および2030年における体外診断薬市場の製品・サービス別売上高シェア（%）
試薬・キット
ソフトウェアとサービス
検査機器

第8章体外診断薬の世界市場：2030年までの収益と予測：技術別

2022年および2030年における体外診断薬市場の技術別売上高シェア（%）
免疫測定/免疫化学
臨床化学
分子診断学
微生物学
血糖自己測定
凝固および止血
血液学
尿検査
その他

第9章体外診断用医薬品の世界市場-用途別収益と2030年までの予測

2022年および2030年における体外診断薬市場の用途別売上高シェア（%）
感染症
糖尿病
腫瘍学
循環器
自己免疫疾患
腎臓内科
その他

第10章体外診断薬の世界市場：エンドユーザー別収益と2030年までの予測

体外診断薬市場の2022年および2030年エンドユーザー別売上高シェア（%）
病院
研究所
在宅医療
その他

第11章地域別分析：体外診断薬市場の収益と2030年までの予測

北米
欧州
アジア太平洋
中東・アフリカ
中南米

第12章業界情勢

北米の体外診断薬市場における成長戦略
有機的展開
無機的展開

第13章企業プロファイル

Abbott Laboratories
F. Hoffmann-La Roche Ltd
Danaher Corp
Siemens AG
Sysmex Corp
Thermo Fisher Scientific Inc
Becton Dickinson and Co
bioMerieux SA
Bio-Rad Laboratories Inc
Qiagen NV

第14章付録

図表

List Of Tables

Table 1. In-Vitro Diagnostics Market Segmentation
Table 2. North America In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 3. North America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 4. North America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. North America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 6. US In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 7. US In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 8. US In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 9. US In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 13. Canada In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 17. Mexico In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Europe In-Vitro Diagnostics Market, For Reagents and Kits by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 19. Europe In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 20. Europe In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 21. Europe In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 22. Germany In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 23. Germany In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 24. Germany In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. Germany In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 26. France In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 27. France In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 28. France In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 29. France In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 30. UK In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 31. UK In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 32. UK In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 33. UK In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 34. Italy In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 35. Italy In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 36. Italy In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 37. Italy In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 38. Spain In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 39. Spain In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 40. Spain In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 41. Spain In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 42. Rest of Europe In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 43. Rest of Europe In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 44. Rest of Europe In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 45. Rest of Europe In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 46. Asia Pacific In-Vitro Diagnostics Market, For Reagents and Kits by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 47. Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 48. Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 49. Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 50. Death Rate Of Cancer in 2020 Globally
Table 51. China In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 52. China In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 53. China In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 54. China In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 55. Japan In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 56. Japan In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 57. Japan In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 58. Japan In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 59. India In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 60. India In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 61. India In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 62. India In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 63. Australia In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 64. Australia In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 65. Australia In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 66. Australia In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 67. South Korea In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 68. South Korea In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 69. South Korea In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 70. South Korea In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 71. Rest of Asia Pacific In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 72. Rest of Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 73. Rest of Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 74. Rest of Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 75. Middle East & Africa In-Vitro Diagnostics Market, For Reagents and Kits by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 76. Middle East & Africa In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 77. Middle East & Africa In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 78. Middle East & Africa In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 79. South Africa In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 80. South Africa In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 81. South Africa In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 82. South Africa In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 83. Saudi Arabia In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 84. Saudi Arabia In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 85. Saudi Arabia In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 86. Saudi Arabia In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 87. UAE In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 88. UAE In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 89. UAE In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 90. UAE In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 91. Rest of Middle East & Africa In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 92. Rest of Middle East & Africa In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 93. Rest of Middle East & Africa In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 94. Rest of Middle East & Africa In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 95. South & Central America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 96. South & Central America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 97. South & Central America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 98. Brazil In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 99. Brazil In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 100. Brazil In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 101. Brazil In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 102. Argentina In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 103. Argentina In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 104. Argentina In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 105. Argentina In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 106. Rest of South & Central America In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 107. Rest of South & Central America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 108. Rest of South & Central America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 109. Rest of South & Central America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 110. Organic Developments Done by Companies
Table 111. Inorganic Developments Done by Companies
Table 112. Glossary of Terms, In-Vitro Diagnostics Market

List Of Figures

Figure 1. In-Vitro Diagnostics Market Segmentation, By Geography
Figure 2. PEST Analysis
Figure 3. In-Vitro Diagnostics Market: Key Industry Dynamics
Figure 4. In-Vitro Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 5. In-Vitro Diagnostics Market Revenue (US$ Mn), 2020 - 2030
Figure 6. Global In-Vitro Diagnostics Market, By Geography Forecast Analysis, 2022 & 2030
Figure 7. In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
Figure 8. Reagents and Kits: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Software and Services: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Instruments: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 12. Immunoassay/ Immunochemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinical Chemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Molecular Diagnostics: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Microbiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Blood Glucose Self-Monitoring: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Coagulation and Hemostasis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Hematology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Urinalysis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
Figure 22. Infectious Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Diabetes: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Oncology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Cardiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Autoimmune Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Nephrology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
Figure 30. Hospitals: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Laboratories: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Homecare: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. North America: In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 35. North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 36. North America: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 37. US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 38. Canada: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 39. Mexico: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 40. Europe: In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 41. Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 42. Europe: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 43. Germany: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 44. France: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 45. UK: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 46. Italy: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 47. Spain: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 48. Rest of Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 49. Asia Pacific: In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 50. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 51. Asia Pacific: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 52. China: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 53. Japan: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 54. India: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 55. Australia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 56. South Korea: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 57. Rest of Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 58. Middle East & Africa: In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 59. Middle East & Africa In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 60. Middle East & Africa: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 61. South Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 62. Saudi Arabia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 63. UAE: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 64. Rest of Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 65. South & Central America: In-Vitro Diagnostics Market, By Key Country - Revenue (2022) (US$ Million)
Figure 66. South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 67. South & Central America: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 68. Brazil: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 69. Argentina: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 70. Rest of South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 71. Growth Strategies in North America In-Vitro Diagnostics Market

Product Code: TIPBT00002657

The in-vitro diagnostics market is expected to grow from US$ 72,393.80 million in 2022 to US$ 1,12,103.51 million by 2030; it is expected to grow at a CAGR of 5.6% from 2022 to 2030. The increasing prevalence of chronic diseases, technological advancements, and the growing geriatric population are the noteworthy factors driving the in-vitro diagnostics market growth.

In vitro diagnostics (IVD) are tests done on samples such as blood or tissues that have been taken from the human body. In-vitro diagnostics are specialized to detect diseases or other conditions that can be used to monitor a person's overall health to help cure, treat, or prevent diseases. Additionally, in-vitro diagnostics may also be utilized for precision medicine to identify patients who are likely to benefit from specific treatments or therapies. Therefore, these in-vitro diagnostics can include next-generation sequencing tests that scan a person's DNA to detect genomic variations.

Increasing Prevalence of Chronic and Infectious Diseases

The world is witnessing an exponential increase in the prevalence of infectious diseases. These diseases are prominently caused due to pathogenic microorganisms, such as viruses, bacteria, and parasites. Factors such as poor sanitary conditions, lack of public hygiene, elevating levels of air pollution, and unavailability of safe drinking water play a significant role in the bolstering prevalence of infectious diseases. According to the Public Health Agency of Canada, the country reported a total of 6,736 cases of hepatitis C (acute, chronic, and unspecified combined) in 2020.

Chronic diseases prominently include cancer, chronic respiratory diseases, diabetes, and heart disease. The incidences of these conditions are skyrocketing globally due to biological risk factors, such as an increase in alcohol and tobacco consumption, adoption of unhealthy diets, lack of physical activity, and prevalence of obesity. Chronic conditions are the leading cause of mortality globally. According to the Centers for Disease Control and Prevention (CDC), 6 in 10 Americans live with at least 1 chronic disease, such as stroke, cancer, heart disease, or diabetes. These chronic diseases are the leading causes of death and disabilities, and burgeoning healthcare costs in the US; the country's healthcare cost was ~US$ 4.1 trillion in 2021. The CDC data also suggests that heart disease is the leading cause of death among men, women, and people of most racial and ethnic groups.

According to CDC data, coronary artery disease (CAD) is the most common cause of mortality among adults. Approximately 375,476 people died due to CAD in 2021. Estimates published in the 2022 National Diabetes Statistics Report by the World Health Organization state that ~422 million people worldwide have diabetes, the majority living in low-and middle-income countries. Moreover, 1.5 million deaths are directly related to diabetes each year. overweight, genetic conditions, aging, sedentary lifestyle, etc., are boosting the prevalence of diabetes. According to estimations published in a Cancer Research UK report, ~18.1 million new cancer cases were reported in the world in 2020, and the number is expected to increase to 28 million by 2040. Hence, the rising prevalence of infectious and chronic diseases such as cardiovascular diseases, cancer, diabetes, and respiratory conditions drives the growth of the in-vitro diagnostics market.

Market Trend

Increasing Demand for Personalized Medicine and Genomics

North America is at the forefront of personalized medicine and genomics research. There is increasing integration of genomics and molecular diagnostics into routine patient care. Companies are involved in developing advanced genetics hold substantial opportunities for the in-vitro diagnostics market. North America, particularly the US and Canada, has been a hub for genomic research centers that contribute notably to understanding and knowledge on the genetic basis of diseases, identification of biomarkers, and development of targeted therapies. Both these countries have launched precision medicine initiatives to integrate genomics into clinical practices. North America has been a leader in cancer genomics, hosting extensive research and clinical trials focused on understanding the genetic factors associated with different types of cancer. These trials aim to evaluate the efficacy of targeted therapies, immunotherapies, and other innovative treatments based on the genetic characteristics of patients' tumors. The American Cancer Society estimates that the US would record 1.9 million new cancer cases (~5,370 cases per day) and 609,820 deaths from cancer in 2023. With such a high incidence, there is a pressing need for effective treatment to improve the quality of life of these patients.

Personalized medicine involves running in-vitro diagnostics tests on patients to stratify them into subgroups based on their unique characteristics. The field of personalized medicine, along with advancements in genomics sequencing, molecular profiling, and other diagnostic technologies, has the potential to revolutionize healthcare by providing targeted, precise, and individualized treatment approaches. Genetics have become increasingly accessible globally. In November 2022, Roche, Cancer Research UK, and the University of Manchester announced the launch of a multidrug, precision medicine DETERMINE trial. The trial seeks to evaluated if available agents, including those that are licensed for more common cancer types, could benefit patients with rare cancer types. The trial recruited both adult and pediatric patients with rare cancer types. Companies such as 23and Me and AncestryDNA offer direct-to-consumer genetic testing kits, allowing individuals to gain insights into their ancestry, genetic traits, and potential health risks. Healthcare providers also offer genetic testing to guide treatment decisions. Thus, the demand for personalized medicine and genomics will propel the growth of the in-vitro diagnostics market during the forecast period.

The "Global In-Vitro Diagnostic Market" is segmented on the basis of product and service, application, technology, end user, and geography. Based on product and service, the market is segmented into reagents and kits, instruments, and software and services. In 2022, the reagents and kits segment held the largest share of the market. The projected growth of the market for reagents and kits is attributed to the tremendous popularity of self-test kits and POC devices, and a rise in availability and adoption automated instruments that simplify jobs and provide accurate results. The increasing cases of viral and fungal infections with inadequate hygienic conditions promote reagent use. Thus, players in the in-vitro diagnostics market are offering superior quality molecular reagents and kits for better patient management and care.

European Medicines Agency, Emergency Use Authorization, Centers for Disease Control and Prevention, International Diabetes Federation, In-Vitro Diagnostic Research are some of the relevant sources referred while preparing the in-vitro diagnostics market research report.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the in-vitro diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global in-vitro diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 In-Vitro Diagnostics Market, by Geography (US$ Million)

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. In-Vitro Diagnostics Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 PEST Analysis

5. In-Vitro Diagnostics Market - Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Increasing Prevalence of Chronic and Infectious Diseases
- 5.1.2 Surge in Demand for In-Vitro Diagnostics During COVID-19 Pandemic
5.2 Market Restraint
- 5.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
5.3 Market Opportunities
- 5.3.1 Integration of IVD with Digital Health Technologies
5.4 Future Trends
- 5.4.1 Increasing Demand for Personalized Medicine and Genomics

6. In-Vitro Diagnostics Market - Global Market Analysis

6.1 In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 - 2030

7. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

7.1 Overview
7.2 In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
7.3 Reagents and Kits
- 7.3.1 Overview
- 7.3.2 Reagents and Kits: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Software and Services
- 7.4.1 Overview
- 7.4.2 Software and Services: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Instruments
- 7.5.1 Overview
- 7.5.2 Instruments: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Technology

8.1 Overview
8.2 In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Immunoassay/ Immunochemistry
- 8.3.1 Overview
- 8.3.2 Immunoassay/ Immunochemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Clinical Chemistry
- 8.4.1 Overview
- 8.4.2 Clinical Chemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Molecular Diagnostics
- 8.5.1 Overview
- 8.5.2 Molecular Diagnostics: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Microbiology
- 8.6.1 Overview
- 8.6.2 Microbiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Blood Glucose Self-Monitoring
- 8.7.1 Overview
- 8.7.2 Blood Glucose Self-Monitoring: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Coagulation and Hemostasis
- 8.8.1 Overview
- 8.8.2 Coagulation and Hemostasis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.9 Hematology
- 8.9.1 Overview
- 8.9.2 Hematology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.10 Urinalysis
- 8.10.1 Overview
- 8.10.2 Urinalysis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.11 Others
- 8.11.1 Overview
- 8.11.2 Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Application

9.1 Overview
9.2 In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Infectious Disease
- 9.3.1 Overview
- 9.3.2 Infectious Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diabetes
- 9.4.1 Overview
- 9.4.2 Diabetes: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Oncology
- 9.5.1 Overview
- 9.5.2 Oncology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Cardiology
- 9.6.1 Overview
- 9.6.2 Cardiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Autoimmune Diseases
- 9.7.1 Overview
- 9.7.2 Autoimmune Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.8 Nephrology
- 9.8.1 Overview
- 9.8.2 Nephrology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.9 Others
- 9.9.1 Overview
- 9.9.2 Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals
- 10.3.1 Overview
- 10.3.2 Hospitals: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Laboratories
- 10.4.1 Overview
- 10.4.2 Laboratories: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Homecare
- 10.5.1 Overview
- 10.5.2 Homecare: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - Geographic Analysis

11.1 North America: In-Vitro Diagnostics Market
- 11.1.1 Overview
- 11.1.2 North America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.3 North America: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.1.4 North America: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.1.5 North America: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.1.6 North America: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.1.7 North America: In-Vitro Diagnostics Market, by Country
  - 11.1.7.1 US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.7.1.1 Overview
    - 11.1.7.1.2 US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.7.1.3 US: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.1.7.1.4 US: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.1.7.1.5 US: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.1.7.1.6 US: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.1.7.2 Canada: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.7.2.1 Overview
    - 11.1.7.2.2 Canada: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.7.2.3 Canada: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.1.7.2.4 Canada: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.1.7.2.5 Canada: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.1.7.2.6 Canada: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.1.7.3 Mexico: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.7.3.1 Overview
    - 11.1.7.3.2 Mexico: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.7.3.3 Mexico: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.1.7.3.4 Mexico: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.1.7.3.5 Mexico: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.1.7.3.6 Mexico: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.2 Europe: In-Vitro Diagnostics Market
- 11.2.1 Overview
- 11.2.2 Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2.3 Europe: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.2.4 Europe: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.2.5 Europe: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.2.6 Europe: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.2.7 Europe: In-Vitro Diagnostics Market, by Country
  - 11.2.7.1 Germany: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.1.1 Overview
    - 11.2.7.1.2 Germany: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.1.3 Germany: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.2.7.1.4 Germany: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.2.7.1.5 Germany: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.2.7.1.6 Germany: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.2.7.2 France: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.2.1 Overview
    - 11.2.7.2.2 France: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.2.3 France: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.2.7.2.4 France: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.2.7.2.5 France: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.2.7.2.6 France: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.2.7.3 UK: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.3.1 Overview
    - 11.2.7.3.2 UK: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.3.3 UK: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.2.7.3.4 UK: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.2.7.3.5 UK: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.2.7.3.6 UK: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.2.7.4 Italy: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.4.1 Overview
    - 11.2.7.4.2 Italy: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.4.3 Italy: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.2.7.4.4 Italy: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.2.7.4.5 Italy: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.2.7.4.6 Italy: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.2.7.5 Spain: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.5.1 Overview
    - 11.2.7.5.2 Spain: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.5.3 Spain: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.2.7.5.4 Spain: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.2.7.5.5 Spain: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.2.7.5.6 Spain: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.2.7.6 Rest of Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.6.1 Overview
    - 11.2.7.6.2 Rest of Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.7.6.3 Rest of Europe: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.2.7.6.4 Rest of Europe: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.2.7.6.5 Rest of Europe: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.2.7.6.6 Rest of Europe: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.3 Asia Pacific: In-Vitro Diagnostics Market
- 11.3.1 Overview
- 11.3.2 Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3.3 Asia Pacific: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.3.4 Asia Pacific: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.3.5 Asia Pacific: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.3.6 Asia Pacific: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.3.7 Asia Pacific: In-Vitro Diagnostics Market, by Country
  - 11.3.7.1 China: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.1.1 Overview
    - 11.3.7.1.2 China: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.1.3 China: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.3.7.1.4 China: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.3.7.1.5 China: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.3.7.1.6 China: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.3.7.2 Japan: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.2.1 Overview
    - 11.3.7.2.2 Japan: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.2.3 Japan: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.3.7.2.4 Japan: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.3.7.2.5 Japan: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.3.7.2.6 Japan: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.3.7.3 India: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.3.1 Overview
    - 11.3.7.3.2 India: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.3.3 India: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.3.7.3.4 India: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.3.7.3.5 India: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.3.7.3.6 India: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.3.7.4 Australia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.4.1 Overview
    - 11.3.7.4.2 Australia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.4.3 Australia: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.3.7.4.4 Australia: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.3.7.4.5 Australia: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.3.7.4.6 Australia: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.3.7.5 South Korea: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.5.1 Overview
    - 11.3.7.5.2 South Korea: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.5.3 South Korea: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.3.7.5.4 South Korea: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.3.7.5.5 South Korea: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.3.7.5.6 South Korea: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.3.7.6 Rest of Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.6.1 Overview
    - 11.3.7.6.2 Rest of Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.7.6.3 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.3.7.6.4 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.3.7.6.5 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.3.7.6.6 Rest of Asia Pacific: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.4 Middle East & Africa: In-Vitro Diagnostics Market
- 11.4.1 Overview
- 11.4.2 Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.4.3 Middle East & Africa: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.4.4 Middle East & Africa: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.4.5 Middle East & Africa: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.4.6 Middle East & Africa: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.4.7 Middle East & Africa: In-Vitro Diagnostics Market, by Country
  - 11.4.7.1 South Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.7.1.1 Overview
    - 11.4.7.1.2 South Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.7.1.3 South Africa: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.4.7.1.4 South Africa: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.4.7.1.5 South Africa: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.4.7.1.6 South Africa: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.4.7.2 Saudi Arabia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.7.2.1 Overview
    - 11.4.7.2.2 Saudi Arabia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.7.2.3 Saudi Arabia: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.4.7.2.4 Saudi Arabia: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.4.7.2.5 Saudi Arabia: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.4.7.2.6 Saudi Arabia: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.4.7.3 UAE: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.7.3.1 Overview
    - 11.4.7.3.2 UAE: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.7.3.3 UAE: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.4.7.3.4 UAE: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.4.7.3.5 UAE: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.4.7.3.6 UAE: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.4.7.4 Rest of Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.7.4.1 Overview
    - 11.4.7.4.2 Rest of Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.7.4.3 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.4.7.4.4 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.4.7.4.5 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.4.7.4.6 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.5 South & Central America: In-Vitro Diagnostics Market
- 11.5.1 Overview
- 11.5.2 South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 11.5.3 South & Central America: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
- 11.5.4 South & Central America: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.5.5 South & Central America: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
- 11.5.6 South & Central America: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.5.7 South & Central America: In-Vitro Diagnostics Market, by Country
  - 11.5.7.1 Brazil: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.7.1.1 Overview
    - 11.5.7.1.2 Brazil: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.7.1.3 Brazil: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.5.7.1.4 Brazil: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.5.7.1.5 Brazil: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.5.7.1.6 Brazil: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.5.7.2 Argentina: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.7.2.1 Overview
    - 11.5.7.2.2 Argentina: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.7.2.3 Argentina: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.5.7.2.4 Argentina: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.5.7.2.5 Argentina: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.5.7.2.6 Argentina: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.5.7.3 Rest of South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.7.3.1 Overview
    - 11.5.7.3.2 Rest of South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.7.3.3 Rest of South & Central America: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 11.5.7.3.4 Rest of South & Central America: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.5.7.3.5 Rest of South & Central America: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 11.5.7.3.6 Rest of South & Central America: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)

12. Industry Landscape

12.1 Overview
12.2 Growth Strategies in North America In-Vitro Diagnostics Market
12.3 Organic Developments
- 12.3.1 Overview
12.4 Inorganic Developments
- 12.4.1 Overview

13. Company Profiles

13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 F. Hoffmann-La Roche Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Danaher Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Siemens AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Sysmex Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Thermo Fisher Scientific Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Becton Dickinson and Co
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 bioMerieux SA
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Bio-Rad Laboratories Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Qiagen NV
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

体外診断薬市場規模・予測、世界・地域シェア、動向、成長機会分析レポート対象範囲：製品・サービス別、技術別、用途別、エンドユーザー別、地域別

In-Vitro Diagnostic Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product & Service, Technology, Application, End User, and Geography

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章体外診断薬市場情勢

第5章体外診断薬市場- 主要産業力学

第6章体外診断薬市場-世界市場分析

第7章体外診断薬の世界市場-2030年までの収益と予測-製品・サービス別

第8章体外診断薬の世界市場：2030年までの収益と予測：技術別

第9章体外診断用医薬品の世界市場-用途別収益と2030年までの予測

第10章体外診断薬の世界市場：エンドユーザー別収益と2030年までの予測

第11章地域別分析：体外診断薬市場の収益と2030年までの予測

第12章業界情勢

第13章企業プロファイル

第14章付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. In-Vitro Diagnostics Market Landscape

5. In-Vitro Diagnostics Market - Key Industry Dynamics

6. In-Vitro Diagnostics Market - Global Market Analysis

7. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

8. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Technology

9. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Application

10. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by End User

11. In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - Geographic Analysis

12. Industry Landscape

13. Company Profiles

14. Appendix

体外診断薬市場規模・予測、世界・地域シェア、動向、成長機会分析レポート対象範囲：製品・サービス別、技術別、用途別、エンドユーザー別、地域別

In-Vitro Diagnostic Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product & Service, Technology, Application, End User, and Geography

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 体外診断薬市場情勢

第5章 体外診断薬市場- 主要産業力学

第6章 体外診断薬市場-世界市場分析

第7章 体外診断薬の世界市場-2030年までの収益と予測-製品・サービス別

第8章 体外診断薬の世界市場：2030年までの収益と予測：技術別

第9章 体外診断用医薬品の世界市場-用途別収益と2030年までの予測

第10章 体外診断薬の世界市場：エンドユーザー別収益と2030年までの予測

第11章 地域別分析：体外診断薬市場の収益と2030年までの予測

第12章 業界情勢

第13章 企業プロファイル

第14章 付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. In-Vitro Diagnostics Market Landscape

5. In-Vitro Diagnostics Market - Key Industry Dynamics

6. In-Vitro Diagnostics Market - Global Market Analysis

7. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

8. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Technology

9. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Application

10. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by End User

11. In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - Geographic Analysis

12. Industry Landscape

13. Company Profiles

14. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章体外診断薬市場情勢

第5章体外診断薬市場- 主要産業力学

第6章体外診断薬市場-世界市場分析

第7章体外診断薬の世界市場-2030年までの収益と予測-製品・サービス別

第8章体外診断薬の世界市場：2030年までの収益と予測：技術別

第9章体外診断用医薬品の世界市場-用途別収益と2030年までの予測

第10章体外診断薬の世界市場：エンドユーザー別収益と2030年までの予測

第11章地域別分析：体外診断薬市場の収益と2030年までの予測

第12章業界情勢

第13章企業プロファイル

第14章付録